CEO on IND status for VGX-100 Open Briefing with CEO & MD Robert Klupacs ... 4-traders (press release) However, we recognise that dry eye disease is one of the most difficult corneal diseases to develop a treatment for, so we're also working on treatments for two niche front-of-the-eye conditions: corneal allograft rejection post corneal transplant; ... |
